Morgan Stanley’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68B | Buy |
46,604,103
+5,574,271
| +14% | +$201M | 0.11% | 165 |
|
|
2025
Q1 | $1.28B | Buy |
41,029,832
+1,497,062
| +4% | +$46.6M | 0.09% | 196 |
|
|
2024
Q4 | $1.01B | Sell |
39,532,770
-1,545,393
| -4% | -$39.4M | 0.07% | 249 |
|
|
2024
Q3 | $1.16B | Sell |
41,078,163
-3,055,283
| -7% | -$86.4M | 0.08% | 217 |
|
|
2024
Q2 | $1.16B | Sell |
44,133,446
-84,439
| -0.2% | -$2.23M | 0.09% | 196 |
|
|
2024
Q1 | $1.34B | Sell |
44,217,885
-48,490,647
| -52% | -$1.47B | 0.11% | 179 |
|
|
2023
Q4 | $2.6B | Buy |
92,708,532
+44,575,917
| +93% | +$1.25B | 0.11% | 166 |
|
|
2023
Q3 | $1.31B | Buy |
48,132,615
+702,754
| +1% | +$19.1M | 0.13% | 144 |
|
|
2023
Q2 | $1.46B | Buy |
47,429,861
+79,403
| +0.2% | +$2.44M | 0.14% | 133 |
|
|
2023
Q1 | $1.71B | Sell |
47,350,458
-1,895,574
| -4% | -$68.3M | 0.18% | 110 |
|
|
2022
Q4 | $1.95B | Sell |
49,246,032
-940,129
| -2% | -$37.2M | 0.22% | 90 |
|
|
2022
Q3 | $2.02B | Sell |
50,186,161
-1,357,010
| -3% | -$54.5M | 0.27% | 71 |
|
|
2022
Q2 | $2.17B | Sell |
51,543,171
-1,998,617
| -4% | -$84M | 0.28% | 71 |
|
|
2022
Q1 | $2.09B | Sell |
53,541,788
-2,688,902
| -5% | -$105M | 0.28% | 81 |
|
|
2021
Q4 | $2.24B | Sell |
56,230,690
-1,074,621
| -2% | -$42.8M | 0.28% | 85 |
|
|
2021
Q3 | $2.07B | Buy |
57,305,311
+6,511,270
| +13% | +$235M | 0.28% | 82 |
|
|
2021
Q2 | $2.08B | Buy |
50,794,041
+2,675,799
| +6% | +$110M | 0.27% | 79 |
|
|
2021
Q1 | $2.1B | Buy |
48,118,242
+24,320,161
| +102% | +$1.06B | 0.31% | 69 |
|
|
2020
Q4 | $1.19B | Buy |
23,798,081
+14,431,463
| +154% | +$722M | 0.18% | 129 |
|
|
2020
Q3 | $394M | Buy |
9,366,618
+3,161,432
| +51% | +$133M | 0.08% | 226 |
|
|
2020
Q2 | $301M | Buy |
+6,205,186
| New | +$301M | 0.07% | 259 |
|